Ability of Serum IgE Concentration to Predict Exacerbation Risk and Benralizumab Efficacy for Patients with Severe Eosinophilic Asthma
Crossref DOI link: https://doi.org/10.1007/s12325-019-01191-2
Published Online: 2019-12-14
Published Print: 2020-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jackson, David J.
Humbert, Marc
Hirsch, Ian
Newbold, Paul
Garcia Gil, Esther
Funding for this research was provided by:
AstraZeneca
Text and Data Mining valid from 2019-12-14
Version of Record valid from 2019-12-14
Article History
Received: 24 October 2019
First Online: 14 December 2019